EMILY MARRIS: Open Payments
NPI 1689191736 · FAYETTEVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,119 in 46 payments from 14 companies in 2025. Trend: 2023 $1,020 · 2024 $500 · 2025 $1,119
Food & beverage: $1,119
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $394 |
| GlaxoSmithKline, LLC. | 12 | $169 |
| GENZYME CORPORATION | 3 | $159 |
| Regeneron Healthcare Solutions, Inc. | 4 | $102 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $45 |
| Amgen Inc. | 2 | $34 |
| Organon LLC | 1 | $25 |
| Lilly USA, LLC | 1 | $25 |
| Pharming Healthcare, Inc. | 1 | $25 |
Products named: TEZSPIRE, DUPIXENT, NUCALA, AIRSUPRA, FASENRA, TRELEGY ELLIPTA, EOHILIA, AYVAKIT.
Industry payments across NY — which companies pay providers there.
